Conduct and analysis of bioavailability and bioequivalence studies, Part A: Oral dosage formulations used for systemic effects : H42-2/56-1992
This guideline provides information about how to establish and conduct bioavailability studies for conventional formulations of oral drugs that are used for systemic effects. The information contained herein deals with conventional formulations of oral drugs that have uncomplicated characteristics. Loose-leaf.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.522174&sl=0
| Department/Agency | Canada. Health and Welfare Canada. Drugs Directorate. |
|---|---|
| Title | Conduct and analysis of bioavailability and bioequivalence studies, Part A: Oral dosage formulations used for systemic effects |
| Series title | Drugs Directorate guidelines |
| Publication type | Series - View Master Record |
| Language | Bilingual-[English | French] |
| Format | Paper |
| Note(s) | "This guideline provides information about how to establish and conduct bioavailability studies for conventional formulations of oral drugs that are used for systemic effects. The information contained herein deals with conventional formulations of oral drugs that have uncomplicated characteristics."--Introduction. Bilingual |
| Publishing information | Ottawa - Ontario : Health and Welfare Canada. 1992. |
| Binding | Loose-leaf |
| Catalogue number |
|
| Subject terms | Biotechnology Drugs |